Bifunctional Aptamer Drug Carrier Enabling Selective and Efficient Incorporation of an Approved Anticancer Drug Irinotecan to Fibrin Gels
Open Access
- 7 December 2020
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 10 (23) , 8755
Abstract
We have previously developed a bifunctional aptamer (bApt) binding to both human thrombin and camptothecin derivative (CPT1), and showed that bApt acts as a drug carrier under the phenomenon named selective oligonucleotide entrapment in fibrin polymers (SOEF), which enables efficient enrichment of CPT1 into fibrin gels, resulting in significant inhibition of tumor cell growth. However, although the derivative CPT1 exhibits anticancer activity, it is not an approved drug. In this study, we evaluated the binding properties of bApt to irinotecan, a camptothecin analog commonly used for anticancer drug therapy, in addition to unmodified camptothecin (CPT). Furthermore, we have revealed that irinotecan binds to bApt like CPT1 and is selectively concentrated on fibrin gels formed around the tumor cells under the SOEF phenomenon to suppress cell proliferation.Keywords
Funding Information
- Japan Agency for Medical Research and Development (AMED) (H355TS)
This publication has 39 references indexed in Scilit:
- Self-assembly of stimuli-responsive imine-linked calix[4]arene nanocapsules for targeted camptothecin deliveryChemical Communications, 2019
- Chondroitin sulfate coated gold nanoparticles: a new strategy to resolve multidrug resistance and thromboinflammationChemical Communications, 2015
- Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancerWorld Journal of Gastroenterology, 2015
- Synthesis and Biological Evaluation of Novel 10-Substituted-7-ethyl-10-hydroxycamptothecin (SN-38) ProdrugsMolecules, 2014
- Self-assembling nanomicelles of a novel camptothecin prodrug engineered with a redox-responsive release mechanismChemical Communications, 2011
- Topoisomerase I inhibitors: camptothecins and beyondNature Reviews Cancer, 2006
- 14-Azacamptothecin: A Potent Water-Soluble Topoisomerase I PoisonJournal of the American Chemical Society, 2004
- The camptothecinsThe Lancet, 2003
- Design and Optimization of Camptothecin Conjugates of Triple Helix-forming Oligonucleotides for Sequence-specific DNA Cleavage by Topoisomerase IJournal of Biological Chemistry, 2002
- Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.Journal of Clinical Investigation, 1998